80 related articles for article (PubMed ID: 14586406)
1. Senescing oral dysplasias are not immortalized by ectopic expression of hTERT alone without other molecular changes, such as loss of INK4A and/or retinoic acid receptor-beta: but p53 mutations are not necessarily required.
Muntoni A; Fleming J; Gordon KE; Hunter K; McGregor F; Parkinson EK; Harrison PR
Oncogene; 2003 Oct; 22(49):7804-8. PubMed ID: 14586406
[TBL] [Abstract][Full Text] [Related]
2. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
McGregor F; Muntoni A; Fleming J; Brown J; Felix DH; MacDonald DG; Parkinson EK; Harrison PR
Cancer Res; 2002 Aug; 62(16):4757-66. PubMed ID: 12183435
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the p16(INK4a) and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts.
Noble JR; Zhong ZH; Neumann AA; Melki JR; Clark SJ; Reddel RR
Oncogene; 2004 Apr; 23(17):3116-21. PubMed ID: 14743210
[TBL] [Abstract][Full Text] [Related]
4. Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype.
Milyavsky M; Shats I; Erez N; Tang X; Senderovich S; Meerson A; Tabach Y; Goldfinger N; Ginsberg D; Harris CC; Rotter V
Cancer Res; 2003 Nov; 63(21):7147-57. PubMed ID: 14612508
[TBL] [Abstract][Full Text] [Related]
5. Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation.
Harada H; Nakagawa H; Oyama K; Takaoka M; Andl CD; Jacobmeier B; von Werder A; Enders GH; Opitz OG; Rustgi AK
Mol Cancer Res; 2003 Aug; 1(10):729-38. PubMed ID: 12939398
[TBL] [Abstract][Full Text] [Related]
6. Inappropriate retinoic acid receptor-beta expression in oral dysplasias: correlation with acquisition of the immortal phenotype.
McGregor F; Wagner E; Felix D; Soutar D; Parkinson K; Harrison PR
Cancer Res; 1997 Sep; 57(18):3886-9. PubMed ID: 9307265
[TBL] [Abstract][Full Text] [Related]
7. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes.
Fu B; Quintero J; Baker CC
Cancer Res; 2003 Nov; 63(22):7815-24. PubMed ID: 14633708
[TBL] [Abstract][Full Text] [Related]
9. Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells.
Wen VW; Wu K; Baksh S; Hinshelwood RA; Lock RB; Clark SJ; Moore MA; Mackenzie KL
Cancer Res; 2006 Nov; 66(22):10691-700. PubMed ID: 17108106
[TBL] [Abstract][Full Text] [Related]
10. Retroviral-mediated expression of telomerase in normal human cells provides a selective growth advantage.
Forsythe HL; Elmore LW; Jensen KO; Landon MR; Holt SE
Int J Oncol; 2002 Jun; 20(6):1137-43. PubMed ID: 12011990
[TBL] [Abstract][Full Text] [Related]
11. Regulation of telomerase and its hTERT messenger in colorectal cancer.
Boldrini L; Faviana P; Gisfredi S; Donati V; Zucconi Y; Ursino S; Simi P; Baldinotti F; Berti P; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
Oncol Rep; 2004 Feb; 11(2):395-400. PubMed ID: 14719074
[TBL] [Abstract][Full Text] [Related]
12. Senescence occurs with hTERT repression and limited telomere shortening in human oral keratinocytes cultured with feeder cells.
Kang MK; Kameta A; Shin KH; Baluda MA; Park NH
J Cell Physiol; 2004 Jun; 199(3):364-70. PubMed ID: 15095283
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C
Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646
[TBL] [Abstract][Full Text] [Related]
14. Immortalization of human small airway epithelial cells by ectopic expression of telomerase.
Piao CQ; Liu L; Zhao YL; Balajee AS; Suzuki M; Hei TK
Carcinogenesis; 2005 Apr; 26(4):725-31. PubMed ID: 15677631
[TBL] [Abstract][Full Text] [Related]
15. Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells.
Duan J; Chen Z; Liu P; Zhang Z; Tong T
Int J Oncol; 2004 Jun; 24(6):1597-605. PubMed ID: 15138605
[TBL] [Abstract][Full Text] [Related]
16. A P53-dependent, telomere-independent proliferative life span barrier in human astrocytes consistent with the molecular genetics of glioma development.
Evans RJ; Wyllie FS; Wynford-Thomas D; Kipling D; Jones CJ
Cancer Res; 2003 Aug; 63(16):4854-61. PubMed ID: 12941806
[TBL] [Abstract][Full Text] [Related]
17. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
Wadhwa R; Takano S; Taira K; Kaul SC
J Gene Med; 2004 Apr; 6(4):439-44. PubMed ID: 15079818
[TBL] [Abstract][Full Text] [Related]
18. p16INK4a downregulation is involved in immortalization of primary human prostate epithelial cells induced by telomerase.
Shao G; Balajee AS; Hei TK; Zhao Y
Mol Carcinog; 2008 Oct; 47(10):775-83. PubMed ID: 18383581
[TBL] [Abstract][Full Text] [Related]
19. Ha-Ras(G12V) induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction.
Takaoka M; Harada H; Deramaudt TB; Oyama K; Andl CD; Johnstone CN; Rhoades B; Enders GH; Opitz OG; Nakagawa H
Oncogene; 2004 Sep; 23(40):6760-8. PubMed ID: 15273725
[TBL] [Abstract][Full Text] [Related]
20. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka.
Takeshima M; Saitoh M; Kusano K; Nagayasu H; Kurashige Y; Malsantha M; Arakawa T; Takuma T; Chiba I; Kaku T; Shibata T; Abiko Y
J Oral Pathol Med; 2008 Sep; 37(8):475-9. PubMed ID: 18284544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
